Number of patient | Patient age (years) | Previous breast cancer | US feature axillary lymph node: axillary lymph node side | US feature axillary lymph node: size (mm of short-axis) | US feature axillary lymph node: focal cortical thickening | US feature axillary lymph node: visible hilar fat | US BI-RADS | Performed biopsy | Histology after biopsy | Vaccination date | US date |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | 29 | No | Left | 18 | No | Yes | E3 | No | No | 02/2021 | 03/2021 |
2 | 66 | Yes: in 2017 IDC in left breast with negative ipsilateral axillary lymph nodes | Left | 22 | No | Yes | E4b | Yes | normal lymphocytes and histiocytes in hematoxylin-eosin staining | 02/2021 | 03/2021 |
3 | 34 | No | Right | 11 | Yes | Yes | E3 | No | 02/2021 | 03/2021 | |
4 | 54 | Yes: in 2015 DCIS in left breast with negative ipsilateral axillary lymph nodes | Left | 23 | No | Yes | E4b | Yes | normal lymphocytes and histiocytes in hematoxylin-eosin staining | 03/2021 | 04/2021 |
5 | 74 | No | Left | 15 | Yes | Yes | E3 | No | 03/2021 | 04/2021 | |
6 | 46 | Yes: in 2018 IDC in left breast with negative ipsilateral axillary lymph nodes | Left | 13 | Yes | Yes | E4b | Yes | normal lymphocytes and histiocytes in hematoxylin-eosin staining | 03/2021 | 05/2021 |
7 | 76 | Yes: in 2018 IDC in right breast with negative ipsilateral axillary lymph nodes | Right | 20 | No | Yes | E4b | Yes | normal lymphocytes and histiocytes in hematoxylin-eosin staining | 04/2021 | 05/2021 |
8 | 59 | Yes: in 2020 IDC in left breast with negative ipsilateral axillary lymph nodes | Left | 20 | No | Yes | E4b | Yes | normal lymphocytes and histiocytes in hematoxylin-eosin staining | 04/2021 | 05/2021 |
9 | 39 | No | Left | 22 | No | Yes | E3 | No | 05/2021 | 05/20121 | |
10 | 28 | No | Right | 20 | Yes | Yes | E3 | No | 05/2021 | 05/2021 |